Latest Insider Transactions at Evolent Health, Inc. (EVH)
This section provides a real-time view of insider transactions for Evolent Health, Inc. (EVH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Evolent Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Evolent Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2025
|
Richard M Jelinek Director |
BUY
Open market or private purchase
|
Indirect |
30,000
+50.0%
|
$270,000
$9.13 P/Share
|
|
Mar 07
2025
|
Brendan B Springstubb Director |
BUY
Open market or private purchase
|
Direct |
15,000
+35.85%
|
$135,000
$9.27 P/Share
|
|
Mar 07
2025
|
Kim Keck Director |
BUY
Open market or private purchase
|
Direct |
10,540
+21.05%
|
$94,860
$9.44 P/Share
|
|
Mar 06
2025
|
Diane Holder Director |
BUY
Open market or private purchase
|
Direct |
2,735
+3.73%
|
$24,615
$9.33 P/Share
|
|
Mar 06
2025
|
Daniel Joseph Mc Carthy PRESIDENT |
BUY
Open market or private purchase
|
Direct |
11,040
+2.76%
|
$99,360
$9.01 P/Share
|
|
Mar 06
2025
|
Seth Blackley Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
55,225
+6.76%
|
$497,025
$9.01 P/Share
|
|
Mar 06
2025
|
Peter J Grua Director |
BUY
Open market or private purchase
|
Direct |
11,040
+37.06%
|
$99,360
$9.01 P/Share
|
|
Mar 06
2025
|
Russell Monroe Glass Director |
BUY
Open market or private purchase
|
Direct |
5,400
+27.45%
|
$48,600
$9.27 P/Share
|
|
Mar 06
2025
|
Craig A. Barbarosh Director |
BUY
Open market or private purchase
|
Direct |
2,000
+5.89%
|
$16,000
$8.81 P/Share
|
|
Mar 04
2025
|
Brendan B Springstubb Director |
BUY
Open market or private purchase
|
Direct |
5,000
+29.69%
|
$40,000
$8.75 P/Share
|
|
Mar 03
2025
|
Brendan B Springstubb Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,842
+50.0%
|
-
|
|
Mar 03
2025
|
Emily Ann Rafferty Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,433
-1.84%
|
$19,464
$8.77 P/Share
|
|
Mar 03
2025
|
Emily Ann Rafferty Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,427
+20.22%
|
-
|
|
Mar 03
2025
|
Daniel Joseph Mc Carthy PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
39,501
-9.46%
|
$316,008
$8.77 P/Share
|
|
Mar 03
2025
|
Daniel Joseph Mc Carthy PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
244,268
+24.77%
|
-
|
|
Mar 03
2025
|
Jonathan Weinberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,544
-1.51%
|
$28,352
$8.77 P/Share
|
|
Mar 03
2025
|
Jonathan Weinberg General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
76,110
+13.49%
|
-
|
|
Mar 03
2025
|
Aammaad Shams Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,168
-4.03%
|
$25,344
$8.77 P/Share
|
|
Mar 03
2025
|
Aammaad Shams Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,801
+16.85%
|
-
|
|
Mar 03
2025
|
Seth Blackley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
72,768
-9.33%
|
$582,144
$8.77 P/Share
|
|
Mar 03
2025
|
Seth Blackley Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
396,371
+22.34%
|
-
|
|
Mar 03
2025
|
John Paul Johnson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
26,872
-8.65%
|
$214,976
$8.77 P/Share
|
|
Mar 03
2025
|
John Paul Johnson Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
148,695
+21.14%
|
-
|
|
Mar 01
2025
|
Emily Ann Rafferty Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,274
-14.63%
|
$74,192
$8.99 P/Share
|
|
Mar 01
2025
|
Daniel Joseph Mc Carthy PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
15,143
-8.04%
|
$121,144
$8.99 P/Share
|
|
Mar 01
2025
|
Jonathan Weinberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
8,808
-5.27%
|
$70,464
$8.99 P/Share
|
|
Mar 01
2025
|
Aammaad Shams Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,546
-10.59%
|
$44,368
$8.99 P/Share
|
|
Mar 01
2025
|
Seth Blackley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,535
-6.93%
|
$228,280
$8.99 P/Share
|
|
Mar 01
2025
|
John Paul Johnson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,246
-5.4%
|
$73,968
$8.99 P/Share
|
|
Aug 23
2024
|
Daniel Joseph Mc Carthy PRESIDENT |
SELL
Open market or private sale
|
Direct |
10,469
-2.67%
|
$335,008
$32.5 P/Share
|
|
Aug 22
2024
|
Jonathan Weinberg General Counsel |
SELL
Open market or private sale
|
Direct |
42,140
-11.16%
|
$1,306,340
$31.0 P/Share
|
|
Aug 22
2024
|
Jonathan Weinberg General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
42,140
+10.01%
|
$632,100
$15.48 P/Share
|
|
Aug 22
2024
|
Daniel Joseph Mc Carthy PRESIDENT |
SELL
Open market or private sale
|
Direct |
23,693
-5.45%
|
$734,483
$31.5 P/Share
|
|
Aug 22
2024
|
Daniel Joseph Mc Carthy PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
4,550
+2.0%
|
$109,200
$24.75 P/Share
|
|
Aug 22
2024
|
John Paul Johnson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
44,693
-20.7%
|
$1,340,790
$30.0 P/Share
|
|
Aug 22
2024
|
Seth Blackley Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
187,904
-31.33%
|
$5,637,120
$30.0 P/Share
|
|
Aug 22
2024
|
Seth Blackley Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
187,904
+10.15%
|
$1,691,136
$9.14 P/Share
|
|
Aug 22
2024
|
Emily Ann Rafferty Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
8,861
-12.26%
|
$265,830
$30.0 P/Share
|
|
Aug 01
2024
|
Aammaad Shams Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,567
-4.67%
|
$56,474
$22.44 P/Share
|
|
Jun 06
2024
|
Mary Bridget Duffy Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,709
+13.84%
|
-
|
|
Jun 06
2024
|
Diane Holder Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,709
+10.2%
|
-
|
|
Jun 06
2024
|
Cheryl Scott Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,709
+13.02%
|
-
|
|
Jun 06
2024
|
Peter J Grua Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,709
+37.67%
|
-
|
|
Jun 06
2024
|
Craig A. Barbarosh Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,709
+20.47%
|
-
|
|
Jun 06
2024
|
Richard M Jelinek Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,709
+34.78%
|
-
|
|
Jun 06
2024
|
Toyin Ajayi Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,709
+38.93%
|
-
|
|
Jun 06
2024
|
Russell Monroe Glass Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,709
+46.49%
|
-
|
|
Jun 06
2024
|
Kim Keck Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,709
+21.01%
|
-
|
|
Mar 02
2024
|
John Paul Johnson Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,020
-4.01%
|
$306,680
$34.41 P/Share
|
|
Mar 02
2024
|
Jonathan Weinberg General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,830
-2.81%
|
$164,220
$34.41 P/Share
|